Zacks Research Issues Negative Outlook for THC Earnings

Tenet Healthcare Co. (NYSE:THC) – Research analysts at Zacks Research dropped their Q2 2026 EPS estimates for Tenet Healthcare in a research note issued to investors on Wednesday, March 26th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $3.33 per share for the quarter, down from their prior forecast of $3.34. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q3 2026 earnings at $3.08 EPS.

Several other equities analysts have also recently issued reports on THC. TD Cowen started coverage on shares of Tenet Healthcare in a research note on Wednesday, February 26th. They issued a “buy” rating and a $175.00 price objective on the stock. Truist Financial decreased their price target on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Barclays reduced their price objective on Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating for the company in a research note on Thursday, February 13th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $177.00 target price on shares of Tenet Healthcare in a report on Thursday, February 13th. Finally, StockNews.com raised Tenet Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, March 13th. Three research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Tenet Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $166.41.

Tenet Healthcare Trading Down 0.7 %

Shares of THC stock opened at $133.55 on Monday. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. The stock has a 50-day simple moving average of $132.49 and a 200 day simple moving average of $141.94. Tenet Healthcare has a fifty-two week low of $90.03 and a fifty-two week high of $171.20. The stock has a market capitalization of $12.70 billion, a P/E ratio of 4.14, a P/E/G ratio of 1.02 and a beta of 2.06.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, topping analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Colonial Trust Co SC raised its holdings in Tenet Healthcare by 85.7% during the fourth quarter. Colonial Trust Co SC now owns 247 shares of the company’s stock valued at $31,000 after buying an additional 114 shares in the last quarter. GeoWealth Management LLC raised its stake in shares of Tenet Healthcare by 39.8% in the 4th quarter. GeoWealth Management LLC now owns 295 shares of the company’s stock valued at $37,000 after acquiring an additional 84 shares in the last quarter. True Wealth Design LLC acquired a new stake in Tenet Healthcare in the 3rd quarter worth approximately $38,000. WR Wealth Planners LLC boosted its position in Tenet Healthcare by 2,836.4% during the fourth quarter. WR Wealth Planners LLC now owns 323 shares of the company’s stock worth $41,000 after purchasing an additional 312 shares during the period. Finally, Smartleaf Asset Management LLC raised its position in shares of Tenet Healthcare by 30.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 471 shares of the company’s stock valued at $59,000 after purchasing an additional 110 shares during the period. Institutional investors own 95.44% of the company’s stock.

Insider Transactions at Tenet Healthcare

In related news, Director J Robert Kerrey sold 9,525 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total value of $1,194,720.75. Following the transaction, the director now owns 27,378 shares in the company, valued at approximately $3,434,022.54. This represents a 25.81 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.93% of the stock is currently owned by company insiders.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.